Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

Latest DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Stock Portfolio

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Performance:
2024 Q3: 14.92%YTD: 22.87%2023: 24.34%
Performance for 2024 Q3 is 14.92%, and YTD is 22.87%, and 2023 is 24.34%.

About DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) and 13F Hedge Fund Stock Holdings

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is a hedge fund based in NEW YORK, NY. On 31-May-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $15.1 Billions. In it's latest 13F Holdings report, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) reported an equity portfolio of $6.7 Billions as of 30 Sep, 2024.

The top stock holdings of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) are NUVL, VTRS, CNC. The fund has invested 30.6% of it's portfolio in NUVALENT INC and 4.2% of portfolio in VIATRIS INC.

The fund managers got completely rid off GILEAD SCIENCES INC (GILD), INTEGRA LIFESCIENCES HLDGS C (IART) and APOGEE THERAPEUTICS INC stocks. They significantly reduced their stock positions in CASTLE BIOSCIENCES INC (CSTL), CYTEK BIOSCIENCES INC (CTKB) and ZOETIS INC (ZTS). DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) opened new stock positions in INDIVIOR PLC, SAVARA INC (SVRA) and VAXCYTE INC (PCVX). The fund showed a lot of confidence in some stocks as they added substantially to NU SKIN ENTERPRISES INC (NUS), MODIVCARE INC (MODV) and BARINGS BDC INC (BBDC).

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Annual Return Estimates Vs S&P 500

Our best estimate is that DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) made a return of 14.92% in the last quarter. In trailing 12 months, it's portfolio return was 55.81%.

New Buys

Ticker$ Bought
alnylam pharmaceuticals inc117,092,000
alphatec hldgs inc105,718,000
indivior plc49,653,300
bicara therapeutics inc45,723,100
savara inc27,414,900
zenas biopharma inc26,445,000
vaxcyte inc25,710,800
dyne therapeutics inc15,648,700
New stocks bought by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Additions

Ticker% Inc.
nu skin enterprises inc919
modivcare inc623
barings bdc inc508
lifemd inc498
mesa labs inc449
insmed inc365
biogen inc276
mativ holdings inc260
Additions to existing portfolio by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Reductions

Ticker% Reduced
castle biosciences inc-98.06
cytek biosciences inc-88.71
zoetis inc-83.3
cooper cos inc-77.63
cms energy corp-77.03
americas car-mart inc-73.15
neogenomics inc-72.64
teledyne technologies inc-71.88
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) reduced stake in above stock

Sold off

Ticker$ Sold
solid biosciences inc-9,885,070
trisalus life sciences inc-543,333
tetra technologies inc del-670,880
talkspace inc-204,038
the beauty health company-113,535
universal ins hldgs inc-782,911
sandridge energy inc-537,629
utz brands inc-667,214
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) got rid off the above stocks

Sector Distribution

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has about 84.5% of it's holdings in Healthcare sector.

Sector%
Healthcare84.5
Others10.1
2.7

Market Cap. Distribution

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has about 14.7% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP48.4
SMALL-CAP24.4
LARGE-CAP14.7
UNALLOCATED11
MICRO-CAP1.1

Stocks belong to which Index?

About 78.8% of the stocks held by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200066.6
Others21.2
S&P 50012.2
Top 5 Winners (%)%
BFLY
butterfly network inc
248.9 %
PHGE
biomx inc
200.0 %
HROW
harrow inc
100.0 %
OMIC
singular genomics systems in
85.4 %
AQST
aquestive therapeutics inc
85.0 %
Top 5 Winners ($)$
NUVL
nuvalent inc
528.6 M
SBTX
ars pharmaceuticals inc
66.4 M
ALHC
alignment healthcare inc
43.5 M
OSCR
oscar health inc
40.6 M
CPRX
catalyst pharmaceuticals inc
39.2 M
Top 5 Losers (%)%
HLVX
hillevax inc
-87.7 %
MODV
modivcare inc
-40.6 %
CMAX
caremax inc
-39.1 %
NUVB
nuvation bio inc
-38.8 %
PRLD
prelude therapeutics inc
-38.5 %
Top 5 Losers ($)$
HLVX
hillevax inc
-50.8 M
NBIX
neurocrine biosciences inc
-32.0 M
MRUS
merus n v
-26.4 M
LRMR
larimar therapeutics inc
-14.9 M
IDYA
ideaya biosciences inc
-10.3 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has 437 stocks in it's portfolio. About 53.5% of the portfolio is in top 10 stocks. HLVX proved to be the most loss making stock for the portfolio. NUVL was the most profitable stock for DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions